Objective: To determine the frequency of myocarditis in patients recovered from COVID-19 infection. Study Design: Analytical Cross-sectional study. Place and Duration of Study: Cardiac Magnetic Resonance Imaging Department, Armed Forces Institute of Cardiology/National Institute of Heart Disease, Rawalpindi Pakistan from Jul 2020 till Apr 2022. Methodology: All patients who underwent Cardiac Magnetic Resonance Imaging after recovery from COVID-19 were enrolled. Non-probability consecutive sampling technique was used for sample selection and was calculated on the basis of Gpower. Data of patients fulfilling the inclusion criteria was selected. All PCR positive cases of COVID-19 who recovered from COVID-19 and completed their 12 days of isolation not exceeding 60 days of 1st Polymerase chain reaction positive, and who have any symptoms of shortness of breath, fatigue and chest pain with reduced left ventricular ejection fraction (LVEF) on 2Dechocardiogram were included in the study. Data was recorded, stored, and analyzed by using SPSS version-21. Quantitative data was reported as Mean±SD. Categorical variables were reported as frequency and percentage. To determine theassociation between different variables Chi square test was used. Results: Total 83 patients were included in this study who recovered from COVID-19 and underwent Cardiovascular magnetic resonance. Mean age of the patients was 39.17±12.9 years. 67(80.72%) were male while 16(19.28%) were females.50(60%) had myocarditis after recovery from COVID-19. This study showed statistically significant association of all the Cardiovascular magnetic resonance imaging findings with Myocarditis (p<0.05) at 95% confidence interval and 5% margin of error. Conclusion: Early detection of COVID-19 related myocarditis will help in better management of patient. In such patients,cardiac Magnetic Resonance Imaging is the modality of choice, since it allows for noninvasive assessment of myocardial edema and fibrosis, as well as therapeutic guidance and improved patient outcomes.
Objective: To assess the myocardial viability on cardiac magnetic resonance imaging compared with single photon emission computed tomography scan in patients with coronary artery disease. Study Design: This study was cross sectional study. Place and Duration of Study: Cardiac Magnetic Resonance Imaging and Nuclear Medicine Departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan, from Dec 2021 to May 2022. Methodology: This study was cross sectional study conducted from December 2021 to May 2022 at Cardiac Magnetic resonance imaging and Nuclear Medicine departments of a Tertiary Cardiac Care Center of Rawalpindi Pakistan. Thirty patients (n=30) with coronary artery disease were selected using non-probability consecutive sampling technique to determine the viable myocardium using cardiac magnetic resonance imaging (CMR) and single photon emission computed tomography (SPECT) scan. Patients with left ventricular dysfunction having ejection fraction equal to or less than forty-five percent and coronary artery disease were included. Results: Using 20 segment models, the mean number of viable segments in SPECT scan and CMR were 16.6±3.18 and 15.47±3.84, respectively while the non-viable segments were 3.4±3.1 and 5.17±4.6, respectively. There was statically little difference in results of Single-photon Emission Computerized Tomography and Cardiac Magnetic Resonance Imaging to determine viable myocardium (p<0.05). Conclusion: Assessment of myocardial viability has keen role in diagnostic and prognostic work up of coronary artery disease patients who are candidates of revascularization. Stunned and hibernating myocardium are two states oreversible myocardial dysfunction.....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.